相似文献
1
Diagnostic dilemma between intestinal Behçet disease and inflammatory bowel disease with pyoderma gangrenosum.
World J Gastroenterol. 2006 Sep 21;12(35):5748-51. doi: 10.3748/wjg.v12.i35.5748.
2
Human leukocyte antigen B27 and B51 double-positive Behçet uveitis.
Arch Ophthalmol. 2007 Oct;125(10):1375-80. doi: 10.1001/archopht.125.10.1375.
3
The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease.
Rheumatol Int. 2006 May;26(7):663-8. doi: 10.1007/s00296-005-0044-9. Epub 2005 Sep 1.
4
A case of SAPHO syndrome with pyoderma gangrenosum and inflammatory bowel disease masquerading as Behçet's disease.
Adv Exp Med Biol. 2003;528:339-41. doi: 10.1007/0-306-48382-3_69.
5
HLA-B27 and HLA-B51 determination in Tunisian healthy subjects and patients with suspected ankylosing spondylitis and Behçet's disease.
Ann N Y Acad Sci. 2009 Sep;1173:564-9. doi: 10.1111/j.1749-6632.2009.04756.x.
6
Primary association of HLA-B51 with Behçet's disease in Ireland.
Br J Ophthalmol. 1998 Jun;82(6):715. doi: 10.1136/bjo.82.6.715.
7
Skin ulcers misdiagnosed as pyoderma gangrenosum.
N Engl J Med. 2003 Mar 13;348(11):1064-6; author reply 1064-6. doi: 10.1056/NEJM200303133481118.
8
Clinical features of pyoderma gangrenosum and current diagnostic trends.
J Am Acad Dermatol. 2011 May;64(5):950-4. doi: 10.1016/j.jaad.2010.01.049. Epub 2011 Feb 3.
9
Neutrophilic folliculitis and the spectrum of pyoderma gangrenosum in inflammatory bowel disease.
Dig Dis Sci. 2007 Jan;52(1):18-24. doi: 10.1007/s10620-006-9361-4. Epub 2006 Dec 8.
10
[Association of HLA with Behçet's disease and its significance].
Zhonghua Nei Ke Za Zhi. 1988 Jun;27(6):363-5, 390-1.
引用本文的文献
1
[Vasculitis mimics].
Z Rheumatol. 2019 Feb;78(1):24-30. doi: 10.1007/s00393-018-0581-8.
本文引用的文献
1
Behçet's disease-like presentation of bullous pyoderma gangrenosum associated with Crohn's disease.
Clin Exp Dermatol. 2006 May;31(3):384-6. doi: 10.1111/j.1365-2230.2006.02093.x.
2
A double-blind trial of depot corticosteroids in Behçet's syndrome.
Rheumatology (Oxford). 2006 Mar;45(3):348-52. doi: 10.1093/rheumatology/kei165. Epub 2005 Nov 1.
3
The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease.
Rheumatol Int. 2006 May;26(7):663-8. doi: 10.1007/s00296-005-0044-9. Epub 2005 Sep 1.
4
Crohn's and Behçet's disease association presenting with superior vena cava thrombosis.
Dig Dis Sci. 2005 Sep;50(9):1698-701. doi: 10.1007/s10620-005-2918-9.
5
Current concepts in the etiology and treatment of Behçet disease.
Surv Ophthalmol. 2005 Jul-Aug;50(4):297-350. doi: 10.1016/j.survophthal.2005.04.009.
6
Ulcerative colitis followed by the development of Behçet's disease.
Intern Med. 2004 Mar;43(3):243-7. doi: 10.2169/internalmedicine.43.243.
7
Urinary nitric oxide levels are increased and correlated with plasma concentrations in patients with Behçet's disease: is it a new urinary activity marker?
Nephrology (Carlton). 2003 Oct;8(5):231-8. doi: 10.1046/j.1440-1797.2003.00180.x.
8
Managing the symptoms of Behçet's disease.
Expert Opin Pharmacother. 2004 Feb;5(2):317-28. doi: 10.1517/14656566.5.2.317.
9
The pathophysiological significance of red blood cell nitric oxide concentrations in inflammatory Behçet's disease.
Mediators Inflamm. 2003 Aug;12(4):255-6. doi: 10.1080/09629350310001599710.
10
Serum leptin concentration is increased in patients with Behçet's syndrome and is correlated with disease activity.
Br J Dermatol. 2002 Aug;147(2):331-6. doi: 10.1046/j.1365-2133.2002.04703.x.
Zotero 插件